{"transactions":[{"id":707055,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-18T01:56:42.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":39078,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001104659-26-084778","document":"tm2620763-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926084778/tm2620763-7_4seq1.xml","form_type":"4"}},{"id":734460,"issuer":{"id":4770,"kind":"organization","name":"AZUL SA"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Member of Strategy Committee"}}],"security":"Common Shares","published_at":"2026-06-17T23:06:34.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":980860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of 980,860 rights to acquire common shares pursuant to the terms of the Issuer's Restricted Shares Granting Plan and applicable documentation thereunder (\"Restricted Shares\"). The Restricted Shares vest over four years as follows: approximately 40% vested on the grant date and approximately 20% will vest on each of May 5, 2027, May 5, 2028 and May 5, 2029, contingent on the reporting person's continued service on each applicable vesting date"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the event that the Issuer does not hold sufficient treasury shares for the settlement of the Restricted Shares on the applicable vesting date, the Reporting Person will be required to subscribe for the Restricted Shares for a nominal price of R$1.00 (one Brazilian real) for all Restricted Shares subject to vesting."}],"balance_after":980860,"source":{"system":"sec-edgar","filing":"0001123292-26-000903","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000112329226000903/form4.xml","form_type":"4"}},{"id":749851,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:10:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":4882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":34672,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4882},"source":{"system":"sec-edgar","filing":"0001104659-26-070519","document":"tm2616870-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926070519/tm2616870-2_4seq1.xml","form_type":"4"}},{"id":749850,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:10:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":4882,"ownership":{"direct":false,"nature":"By JZ Advisors LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held directly by JZ Advisors LLC, a limited liability company, of which the Reporting Person is a 100% owner and managing member."}],"balance_after":12913,"source":{"system":"sec-edgar","filing":"0001104659-26-070519","document":"tm2616870-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926070519/tm2616870-2_4seq1.xml","form_type":"4"}},{"id":882258,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-26T01:59:00.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":3984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."}],"balance_after":39554,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3984},"source":{"system":"sec-edgar","filing":"0001104659-26-019929","document":"tm267115-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926019929/tm267115-8_4seq1.xml","form_type":"4"}},{"id":952153,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:05:02.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":4384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2024, the Reporting Person was granted 10,942 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 4 below."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2024, the Reporting Person was granted 10,942 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 4 below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects that the Reporting Person received 6,711 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. (\"Par Health\") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health."}],"balance_after":35570,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4384},"source":{"system":"sec-edgar","filing":"0001104659-26-000785","document":"tm261751-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926000785/tm261751-8_4seq1.xml","form_type":"4"}},{"id":952152,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-05T23:05:02.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":4384,"ownership":{"direct":false,"nature":"By JZ Advisors LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held directly by JZ Advisors LLC, a limited liability company, of which the Reporting Person is a 100% owner and managing member."}],"balance_after":8031,"source":{"system":"sec-edgar","filing":"0001104659-26-000785","document":"tm261751-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465926000785/tm261751-8_4seq1.xml","form_type":"4"}},{"id":1064191,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-19T01:07:17.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":4062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":33243,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4062},"source":{"system":"sec-edgar","filing":"0001104659-25-079950","document":"tm2523680-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465925079950/tm2523680-9_4seq1.xml","form_type":"4"}},{"id":1076449,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:53:00.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":21886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."}],"balance_after":29181,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21886},"source":{"system":"sec-edgar","filing":"0001104659-25-073797","document":"tm2522414-27_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465925073797/tm2522414-27_4seq1.xml","form_type":"4"}},{"id":1318831,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:05:50.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":3647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2024, the reporting person was granted 10,942 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2024, the reporting person was granted 10,942 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":7295,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3647},"source":{"system":"sec-edgar","filing":"0001104659-25-000378","document":"tm2432211-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465925000378/tm2432211-16_4seq1.xml","form_type":"4"}},{"id":1318830,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T22:05:50.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":3647,"ownership":{"direct":false,"nature":"By JZ Advisors LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares are held directly by JZ Advisors LLC, a limited liability company, of which the reporting person is a 100% owner and managing member."}],"balance_after":3647,"source":{"system":"sec-edgar","filing":"0001104659-25-000378","document":"tm2432211-16_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465925000378/tm2432211-16_4seq1.xml","form_type":"4"}},{"id":1634409,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":25916,"kind":"person","name":"Zinman Jon","position":1,"cik":"0002001886","reported_name":"Zinman Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-20T21:20:20.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":false,"shares":10942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") will be settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Person is an employee of Silver Point Capital, L.P. (\"Silver Point\"). Mr. Zinman has an understanding with Silver Point pursuant to which he will hold any compensation received as a director for the benefit of Silver Point and certain of its affiliates. Mr. Zinman disclaims beneficial ownership of any of the Issuer's securities held by Silver Point or its affiliates."}],"balance_after":10942,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10942},"source":{"system":"sec-edgar","filing":"0001104659-24-025536","document":"tm245307-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001886/000110465924025536/tm245307-19_4seq1.xml","form_type":"4"}}]}